{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:16:17Z","timestamp":1787807777518,"version":"build-2784847793"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T00:00:00Z","timestamp":1536883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2019,2,15]]},"DOI":"10.1007\/s10461-018-2261-8","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T10:51:14Z","timestamp":1536922274000},"page":"504-512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Vaginal Ring Use in a Phase 3 Microbicide Trial: A Comparison of Objective Measures and Self-reports of Non-adherence in ASPIRE"],"prefix":"10.1007","volume":"23","clinical-trial-number":[{"clinical-trial-number":"nct01617096","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Barbara S.","family":"Mensch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra A.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marla","family":"Husnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia Matovu","family":"Kiweewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley J.","family":"Mayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared M.","family":"Baeten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thesla","family":"Palanee-Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"van der Straten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the MTN-020\/ASPIRE study team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,14]]},"reference":[{"key":"2261_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874613601610010034","volume":"10","author":"AB Kharsany","year":"2016","unstructured":"Kharsany AB, Karim QA. HIV infection and AIDS in Sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34.","journal-title":"Open AIDS J"},{"issue":"1","key":"2261_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11904-012-0141-9","volume":"10","author":"A van der Straten","year":"2012","unstructured":"van der Straten A, Montgomery ET, Hartmann M, Minnis A. Methodological lessons from clinical trials and the future of microbicide research. Curr HIV\/AIDS Rep. 2012;10(1):89\u2013102.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"2261_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"issue":"5","key":"2261_CR4","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1007\/s10461-009-9635-x","volume":"14","author":"EE Tolley","year":"2010","unstructured":"Tolley EE, Harrison PF, Goetghebeur E, et al. Adherence and its measurement in phase 2\/3 microbicide trials. AIDS Behav. 2010;14(5):1124\u201336.","journal-title":"AIDS Behav"},{"issue":"16","key":"2261_CR5","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1097\/QAD.0000000000000801","volume":"29","author":"A van der Straten","year":"2015","unstructured":"van der Straten A, Montgomery ET, Musara P, et al. Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS. 2015;29(16):2161\u201371.","journal-title":"AIDS"},{"issue":"2","key":"2261_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s10461-016-1609-1","volume":"21","author":"ET Montgomery","year":"2017","unstructured":"Montgomery ET, Mensch B, Musara P, et al. Misreporting of product adherence in the MTN-003\/VOICE trial for HIV prevention in Africa: participants\u2019 explanations for dishonesty. AIDS Behav. 2017;21(2):481\u201391.","journal-title":"AIDS Behav"},{"key":"2261_CR7","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2147\/IJWH.S34030","volume":"5","author":"AR Thurman","year":"2013","unstructured":"Thurman AR, Clark MR, Hurlburt JA, Doncel GF. Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies. Int J Women\u2019s Health. 2013;5:695\u2013708.","journal-title":"Int J Women\u2019s Health."},{"issue":"10","key":"2261_CR8","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1097\/QAD.0000000000000280","volume":"28","author":"A Nel","year":"2014","unstructured":"Nel A, Haazen W, Nuttall J, Romano J, Rosenberg Z, van Niekerk N. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women. AIDS. 2014;28(10):1479\u201387.","journal-title":"AIDS"},{"issue":"22","key":"2261_CR9","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","volume":"375","author":"JM Baeten","year":"2016","unstructured":"Baeten JM, Palanee-Phillips T, Brown ER, et al. Use of a vaginal ring containing dapivirine for HIV-1 prevention in women. N Engl J Med. 2016;375(22):2121\u201332.","journal-title":"N Engl J Med"},{"issue":"1","key":"2261_CR10","doi-asserted-by":"publisher","first-page":"20746","DOI":"10.7448\/IAS.19.1.20746","volume":"19","author":"RM Stalter","year":"2016","unstructured":"Stalter RM, Moench TR, MacQueen KM, Tolley EE, Owen DH. Biomarkers and biometric measures of adherence to use of ARV-based vaginal rings. J Int AIDS Soc. 2016;19(1):20746.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"2261_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10461-012-0326-7","volume":"17","author":"BJ Feldman","year":"2013","unstructured":"Feldman BJ, Fredericksen RJ, Crane PK, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav. 2013;17(1):307\u201318.","journal-title":"AIDS Behav"},{"issue":"1","key":"2261_CR12","doi-asserted-by":"crossref","first-page":"206426","DOI":"10.7448\/IAS.19.1.20642","volume":"19","author":"A van der Straten","year":"2016","unstructured":"van der Straten A, Brown ER, Marrazzo JM, et al. Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study. J Int AIDS Soc. 2016;19(1):206426.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"2261_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1097\/QAI.0000000000000525","volume":"68","author":"AL Corneli","year":"2015","unstructured":"Corneli AL, McKenna K, Perry B, et al. The science of being a study participant: FEM-PrEP participants\u2019 explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. J Acquir Immune Defic Syndr. 2015;68(5):578\u201384.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"2261_CR14","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10461-012-0333-8","volume":"17","author":"AM Minnis","year":"2013","unstructured":"Minnis AM, et al. Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women. AIDS Behav. 2013;17(2):737\u201347.","journal-title":"AIDS Behav."},{"issue":"11","key":"2261_CR15","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1007\/s10461-016-1312-2","volume":"20","author":"BS Mensch","year":"2016","unstructured":"Mensch BS, Brown ER, Liu K, et al. Reporting of adherence in the VOICE trial: did disclosure of product nonuse increase at the termination visit? AIDS Behav. 2016;20(11):2654\u201361.","journal-title":"AIDS Behav"},{"issue":"2","key":"2261_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1353\/dem.2003.0017","volume":"40","author":"BS Mensch","year":"2003","unstructured":"Mensch BS, Hewett PC, Erulkar AS. The reporting of sensitive behavior by adolescents: a methodological experiment in Kenya. Demography. 2003;40(2):247\u201368.","journal-title":"Demography"},{"issue":"1","key":"2261_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1728-4465.2014.00375.x","volume":"45","author":"CA Kelly","year":"2014","unstructured":"Kelly CA, Hewett PC, Mensch BS, et al. Using biomarkers to assess the validity of sexual behavior reporting across interview modes among young women in Kampala, Uganda. Stud Fam Plan. 2014;45(1):43\u201358.","journal-title":"Stud Fam Plan"},{"issue":"2","key":"2261_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.socscimed.2003.10.031","volume":"59","author":"S Nnko","year":"2004","unstructured":"Nnko S, Boerma JT, Urassa M, Mwaluko G, Zaba B. Secretive females or swaggering males? An assessment of the quality of sexual partnership reporting in rural Tanzania. Soc Sci Med. 2004;59(2):299\u2013310.","journal-title":"Soc Sci Med"},{"key":"2261_CR19","doi-asserted-by":"publisher","first-page":"ii49","DOI":"10.1136\/sti.2004.011924","volume":"80","author":"ML Plummer","year":"2004","unstructured":"Plummer ML, Ross DA, Wight D, et al. A bit more truthful: the validity of adolescent sexual behavior data collected in rural northern Tanzania using five methods. Sex Transm Infect. 2004;80:ii49\u201356.","journal-title":"Sex Transm Infect"},{"key":"2261_CR20","doi-asserted-by":"publisher","first-page":"ii28","DOI":"10.1136\/sti.2004.012674","volume":"80","author":"B Zaba","year":"2004","unstructured":"Zaba B, Pisani E, Slaymaker E, Boerma JT. Age at first sex: understanding recent trends in African demographic surveys. Sex Transm Infect. 2004;80:ii28\u201335.","journal-title":"Sex Transm Infect"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-018-2261-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-018-2261-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-018-2261-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T15:49:46Z","timestamp":1628610586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-018-2261-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,14]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2,15]]}},"alternative-id":["2261"],"URL":"https:\/\/doi.org\/10.1007\/s10461-018-2261-8","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,14]]},"assertion":[{"value":"14 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The ASPIRE trial protocol was approved by the ethics review committee at each site.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All participants provided written informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}